[go: up one dir, main page]

ATE228516T1 - Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung - Google Patents

Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung

Info

Publication number
ATE228516T1
ATE228516T1 AT00949575T AT00949575T ATE228516T1 AT E228516 T1 ATE228516 T1 AT E228516T1 AT 00949575 T AT00949575 T AT 00949575T AT 00949575 T AT00949575 T AT 00949575T AT E228516 T1 ATE228516 T1 AT E228516T1
Authority
AT
Austria
Prior art keywords
imidazoline derivatives
fluorinated
benzodioxan
production
therapeutic use
Prior art date
Application number
AT00949575T
Other languages
English (en)
Inventor
Thierry Imbert
Patrice Mayer
Marc Marien
Peters Pauwels
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE228516T1 publication Critical patent/ATE228516T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00949575T 1999-06-29 2000-06-29 Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung ATE228516T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908302A FR2795727B1 (fr) 1999-06-29 1999-06-29 Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
PCT/FR2000/001825 WO2001000619A1 (fr) 1999-06-29 2000-06-29 Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
ATE228516T1 true ATE228516T1 (de) 2002-12-15

Family

ID=9547432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949575T ATE228516T1 (de) 1999-06-29 2000-06-29 Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung

Country Status (16)

Country Link
US (1) US6610725B1 (de)
EP (1) EP1192152B1 (de)
JP (1) JP4608160B2 (de)
CN (1) CN1139588C (de)
AT (1) ATE228516T1 (de)
AU (1) AU778796B2 (de)
BR (1) BR0012042A (de)
CA (1) CA2377186A1 (de)
DE (1) DE60000880T2 (de)
DK (1) DK1192152T3 (de)
ES (1) ES2186654T3 (de)
FR (1) FR2795727B1 (de)
MX (1) MXPA02000256A (de)
PT (1) PT1192152E (de)
WO (1) WO2001000619A1 (de)
ZA (1) ZA200200009B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
US20110165037A1 (en) * 2010-01-07 2011-07-07 Ismagilov Rustem F Interfaces that eliminate non-specific adsorption, and introduce specific interactions
EA201990158A1 (ru) * 2016-06-29 2019-05-31 Орион Корпорейшн Производные бензодиоксана и их фармацевтическое применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions

Also Published As

Publication number Publication date
EP1192152B1 (de) 2002-11-27
CA2377186A1 (fr) 2001-01-04
DE60000880T2 (de) 2003-08-28
FR2795727A1 (fr) 2001-01-05
BR0012042A (pt) 2002-07-09
FR2795727B1 (fr) 2001-09-21
DE60000880D1 (de) 2003-01-09
MXPA02000256A (es) 2002-06-21
CN1139588C (zh) 2004-02-25
AU6289000A (en) 2001-01-31
US6610725B1 (en) 2003-08-26
CN1361776A (zh) 2002-07-31
JP2003503406A (ja) 2003-01-28
ES2186654T3 (es) 2003-05-16
WO2001000619A1 (fr) 2001-01-04
PT1192152E (pt) 2003-04-30
DK1192152T3 (da) 2003-03-17
AU778796B2 (en) 2004-12-23
JP4608160B2 (ja) 2011-01-05
EP1192152A1 (de) 2002-04-03
ZA200200009B (en) 2002-09-25

Similar Documents

Publication Publication Date Title
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
SE0104334D0 (sv) Therapeutic agents
BG103207A (en) Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation
DE60000880D1 (de) Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
FR2643076B1 (fr) Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
TW336929B (en) Benzenesulphonamide derivatives, their preparation and their application in therapy
EP0452926A3 (en) 5-aryl-4-alkyl-3h-1,2,4-triazole-3-thiones useful as memory enhancers
ES2039485T3 (es) Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido.
MX7667A (es) Procedimiento para la preparacion de nuevas butenamidas farmaceuticas y compuestos relacionados.
ES557597A0 (es) Procedimiento para preparar acidos hexenoicos
ATE195313T1 (de) 3-substituierte 1-arylindolverbindungen
DE69932269D1 (de) Herstellung optisch aktiver Cyclohexylphenylglykolsäureester
ES2110974T3 (es) Procedimiento para la preparacion de (s)-vinil y de (s)-alenil-gaba.
NZ216613A (en) 7-fluoro prostacyclins and compositions
IT1268414B1 (it) Enantiomeri farmacologicamente attivi
DK141282A (da) Fremgangsmaade til fremstilling af morpholiner
PT86852A (pt) Procede de preparation des nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.
ATE99306T1 (de) Antagonisten von leukotrien d4.
ATE100449T1 (de) 1,3-dioxolan-benzoesaeure und derivate davon.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1192152

Country of ref document: EP

REN Ceased due to non-payment of the annual fee